- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04252560
The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.
May 8, 2024 updated by: Konstantinos Tsimogiannis, Uppsala University Hospital
The role of gut microbiota in anastomosis insufficiency in patients operated for colorectal cancer and for peritoneal carcinomatosis is going to be investigated.
This is a pilot study.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
45
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Uppsala, Sweden, 75185
- Uppsala University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
All patients who meet the inclusion criteria and have none of the exclusion criteria are going to be asked to participate in the study
Description
Inclusion Criteria Colorectal group
- adenocarcinom in colon or rektum
- curative operation planed
- direct anastomose plan
- elective surgery
Inclusion Criteria HIPEC group :
- All patients with appendix, colon or rectal cancer accepted for CRS+HIPEC
Exclusion Criteria:
- Ongoing antibiotics treatment
- antibiotics treatment in the last 6 months
- acute surgery
- palliative surgery
- Ulcerös colitis or Crohns disease
- Prior colectomy
- Small intestine stoma before the operation
- neoadjuvant treatment
- Colon preparation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Colorectal
30 patients operated for colorectal cancer
|
No special interventions are going to be performed.
Fecal samples are going to be taken and analysed
|
|
HIPEC
15 patients operated with CRS+HIPEC for peritoneal carcinomatosis
|
No special interventions are going to be performed.
Fecal samples are going to be taken and analysed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbiome
Time Frame: 30 days
|
Change in microbiome in case of insufficiency of the anastomosis
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 31, 2020
Primary Completion (Actual)
January 31, 2024
Study Completion (Actual)
January 31, 2024
Study Registration Dates
First Submitted
January 31, 2020
First Submitted That Met QC Criteria
January 31, 2020
First Posted (Actual)
February 5, 2020
Study Record Updates
Last Update Posted (Actual)
May 9, 2024
Last Update Submitted That Met QC Criteria
May 8, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Peritoneal Diseases
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Abdominal Neoplasms
- Carcinoma
- Colorectal Neoplasms
- Peritoneal Neoplasms
Other Study ID Numbers
- 2019-04562
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Not allowed by the Ethical Committee
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.